AI assistant
InfuSystem Holdings, Inc — Director's Dealing 2015
Nov 20, 2015
33639_dirs_2015-11-19_70446ce9-ccd6-45ed-a367-c641685b71ee.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InfuSystem Holdings, Inc (INFU)
CIK: 0001337013
Period of Report: 2015-11-17
Reporting Person: Steen Eric K (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-11-17 | Common Stock | P | 1400 | $2.91 | Acquired | 156156 | Direct |
| 2015-11-18 | Common Stock | P | 100 | $2.84 | Acquired | 156256 | Direct |
| 2015-11-19 | Common Stock | P | 961 | $2.84 | Acquired | 157217 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.84 to $2.93, inclusive. The reporting person undertakes to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1).
F2: Includes 9,177 shares acquired under the InfuSystem Holdings, Inc. Employee Stock Purchase Plan.
F3: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.83 to $2.84, inclusive. The reporting person undertakes to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3).